Lenalidomide for patients with red blood cell transfusion-dependent low- or intermediate-1-risk IPSS myelodysplastic syndromes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lenalidomide for patients with red blood cell transfusion-dependent low- or intermediate-1-risk IPSS myelodysplastic syndromes

Published:2013-02-28 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Zeng Yan,Duan Xin,Long Dan,Zhou Ruiqing,Yang Songtao

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010413/epdf/full

Reference36 articles.

1. Age-related incidence and other epidemiological aspects of myelodysplasitic syndrome;Aul;British Journal of Heamatology,1992

2. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group;Bennett;British Journal of Haematology,1976

3. Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution;Bernasconi;Leukemia,2005

4. Bethesda MD Cancer Therapy Evaluation Program CTC v2.0 and Common Terminology Criteria for Adverse Events v3.0 (CTCAE) National Cancer Institute, 2007. http://ctep.cancer.gov/reporting/ctc.html

5. The genetics of the myelodysplastic syndromes: classical cytogenetics and recent molecular insights;Cherian;Hematology,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP